Cite

HARVARD Citation

    Riess, J. et al. (2015). Casting a wide net: HSP90 inhibition to circumvent resistance to TKIs in EGFR-mutated and ALK-rearranged NSCLC. Lung cancer management. pp. 5-8. [Online]. 
  
Back to record